Venture capital firm based in Edinburgh, UK
Bioliberty raises £7.6m to reduce post-acute readmissions with computer vision and AI. Read more
Earth Blox raises £6m to quantify nature-related financial risk using satellite data. Read more
BIOCAPTIVA raises £1.6m seed to commercialise magnetic beads for liquid biopsy prep. Read more
1nhaler raises £1.5m to advance its credit-card-sized single-dose inhaler. Read more
CSignum secures £6 million in Series A funding to enhance IoT connectivity through innovative underwater and underground communication solutions. Read more
Glasgow-based startup Neuranics secures £1.9M in funding to expand its magnetic sensor technology, revolutionizing health monitoring and enhancing interactions in the metaverse. Read more
BDD Pharma secures £2M funding to accelerate expansion of its drug formulation and clinical trial services, propelled by its patented oral drug delivery technology OralogiK™. Read more
Cytomos secures £4 million to enhance cell analysis tech, aiming for market disruption in biopharma by 2024. Exciting times ahead. Read more
| Healthtech | 38.5% |
| Biotech | 30.8% |
| Edtech | 7.7% |
| Data | 7.7% |
| Fintech | 7.7% |
| Mobility | 7.7% |